SCHEMBL3727650

SCHEMBL3727650

COC(C(=O)OCc1ccccc1)C(C=O)c1ccc([N+](=O)[O-])c(C(=O)N(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
LMNA P02545 2/20 0.37
KMT2A Q03164 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
MITF O75030 1/20 0.35
MAPK1 P28482 1/20 0.35
CCR6 P51684 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SLC6A4 P31645 1/20 0.34
GSTP1 P09211 1/20 0.34
GSTM2 P28161 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP3A4 P08684 2/20 0.33
ITGA4 P13612 1/20 0.33
ITGB7 P26010 1/20 0.33
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3727645 0.75 ALDH1A1 (0.41) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL3727651 0.75 ABCB1 (0.37) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL5064967 0.72 BACE1 (0.51) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL402138 0.71 KMT2A (0.42) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL12185923 0.71 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1MAPTHTT
SCHEMBL2597771 0.69 KMT2A (0.46) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL2597772 0.69 KMT2A (0.46) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL3722430 0.69 ALDH1A1 (0.44) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL2597715 0.69 KMT2A (0.41) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL2598054 0.68 KMT2A (0.45) LMNAKMT2AMEN1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075367-A1 Ester compound and medicinal use thereof LIPC, CES1, MTTP ALDH1A1 564/4885LMNA 2248/4885KMT2A 2890/4885
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF LIPC, CES1, MTTP ALDH1A1 603/4885LMNA 2365/4885KMT2A 3106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.